Presented by :ARIF KHAN
4th GROUP
5th YEAR
 Ethambutol is used with other medications to
treat tuberculosis (TB). Ethambutol is an
antibiotic and works by stopping the growth
of bacteria.
 This antibiotic treats only bacterial
infections. It will not work for viral infections
(such as common cold, flu). Unnecessary use
or misuse of any antibiotic can lead to its
decreased effectiveness
 This drug may also be used with other
medications to help treat a certain serious
infection (Mycobacterium avium complex-
MAC). It may also be used with other
medications to prevent the MAC infection
from occurring again in people with
advanced HIV disease.
 It is sold under the trade
names Myambutol and Servambutol.
 Ethambutol diffuses into actively growing M.
tuberculosis such as tubercle bacilli.
Ethambutol appears to inhibit the synthesis
of one or more metabolites, thus causing
impairment of cell metabolism, arrest of
multiplication, and cell death . No cross
resistance with other available antimicrobial
agents has been demonstrated.
It is well absorbed from
the gastrointestinal tract and well
distributed in body tissues and
fluids. 50% is excreted unchanged in
urine.
 Ethambutol is distributed to most tissues and
body fluids, except CSF. Ethambutol does not
penetrate intact meninges, but 10 to 50%
may penetrate the meninges of patients with
tuberculous meningitis.
 Rifampin—High to very high (89%).
Isoniazid—Very low (0 to 10%).
Pyrazinamide—Low (10 to 20%).
Pyrazinoic acid—Low (approximately 31%).
Ethambutol—Low (20 to 30%).
 Up to 15% of ethambutol is metabolized to
inactive metaboliteIsoniazid—1 to 2 hours{08}{09}.

 Pyrazinamide—1 to 2 hours
Pyrazinoic acid—4 to 5 hours
Ethambutol—2 to 4 hours
Time to peak serum concentration
Rifampin—1.5 to 4 hours after oral
administration
 Ethambutol:
2 to 5 mcg/mL after a single dose of 25
mg/kg.
 Ethambutol—
Renal; by glomerular filtration and
tubular secretion; up to 80% excreted within
24 hours (at least 50% excreted unchanged
and up to 15% as inactive metabolites).
 Fecal; 20% excreted unchanged.
 In dialysis—
ethambutol is removed from the blood
by hemodialysis and peritoneal dialysis.
 Incidence more frequent:
Hepatitis (dark urine; yellow eyes or skin)
hepatitis prodromal symptoms (loss of
appetite; nausea and vomiting; unusual
tiredness or weakness)
peripheral neuritis (clumsiness or
unsteadiness; numbness, tingling, burning, or
pain in hands and feet )
“Flu-like” syndrome (chills; difficulty in
breathing; dizziness; fever; headache;
muscle and bone pain; shivering)
gouty arthritis, acute (chills; pain and
swelling of joints, especially big toe, ankle,
or knee; tense, hot skin over affected joints)
hypersensitivity (itching; redness; skin
rash).
Incidence less frequent
 Blood dyscrasias (sore throat; unusual
bleeding or bruising)
interstitial nephritis (bloody or cloudy urine;
greatly decreased frequency of urination or
amount of urine)
neurotoxicity (seizures; mental depression;
mood or other mental changes )
retrobulbar optic neuritis (blurred vision or
loss of vision, with or without eye pain).
Incidence rare
 Before taking ethambutol, tell your doctor or
pharmacist if you are allergic to it; or if you
have any other allergies. This product may
contain inactive ingredients, which can cause
allergic reactions or other problems.
 Before using this medication, tell your
doctor or pharmacist your medical history,
especially of: eye problems (such as optic
neuritis, cataracts, diabetic
retinopathy),liver disease, kidney disease,
alcohol use.
Ethambutol crosses the placenta, resulting in
fetal plasma concentrations that are
approximately 30% of maternal plasma
concentrations. However, problems in humans
have not been documented.
 Disulfiram (concurrent use in alcoholics
may result in increased incidence of CNS
effects such as dizziness, incoordination,
irritability, or insomnia; reduced dosage or
discontinuation of disulfiram may be
necessary.
 For specific information on the agents used
in the management of rifampin, isoniazid,
pyrazinamide, and ethambutol overdose, :
• Pyridoxine (Systemic) in monograph;
• Diazepam in Benzodiazepines
(Systemic)monograph; and/or
• Thiopental in Barbiturates
(Systemic) monograph.
 Conditions affecting use, especially:
Hypersensitivity to rifampin, isoniazid,
pyrazinamide, ethionamide, niacin (nicotinic acid),
rifabutin, rifapentine, or other chemically related
medications
 Pregnancy—Rifampin, isoniazid, and ethambutol
cross the placenta
 Breast-feeding—Rifampin, isoniazid, pyrazinamide,
and ethambutol are distributed into breast milk
 Use in children——Ethambutol generally is not
recommended in children whose visual acuity
cannot be monitored (younger than 6 years of age)
 » Regular visits to physician to check progress, as well as ophthalmologic
examinations if signs of optic neuritis occur
 » Checking with physician if no improvement within 2 to 3 weeks
 » Using an alternate method of contraception if taking estrogen-containing
oral contraceptives concurrently
 » Avoiding alcoholic beverages while taking this medication
 » Checking with physician if vascular reactions occur following concurrent
ingestion of cheese or fish with isoniazid-containing medication
 » Checking with physician if blurred vision or loss of vision occurs
 » Medication causes urine, feces, saliva, sputum, sweat, and tears to turn
reddish-orange to reddish-brown and may also permanently discolor soft
contact lenses; avoiding the wearing of soft contact lenses
 http://www.drugs.com/mmx/rifampin-
isoniazid-pyrazinamide-and-ethambutol.html
 http://www.webmd.com/drugs/2/drug-
8082/ethambutol-oral/details#
 http://www.medicinenet.com/ethambutol-
oral/page2.htm
Ethambutol by arif khan

Ethambutol by arif khan

  • 1.
    Presented by :ARIFKHAN 4th GROUP 5th YEAR
  • 2.
     Ethambutol isused with other medications to treat tuberculosis (TB). Ethambutol is an antibiotic and works by stopping the growth of bacteria.  This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness
  • 3.
     This drugmay also be used with other medications to help treat a certain serious infection (Mycobacterium avium complex- MAC). It may also be used with other medications to prevent the MAC infection from occurring again in people with advanced HIV disease.  It is sold under the trade names Myambutol and Servambutol.
  • 4.
     Ethambutol diffusesinto actively growing M. tuberculosis such as tubercle bacilli. Ethambutol appears to inhibit the synthesis of one or more metabolites, thus causing impairment of cell metabolism, arrest of multiplication, and cell death . No cross resistance with other available antimicrobial agents has been demonstrated.
  • 5.
    It is wellabsorbed from the gastrointestinal tract and well distributed in body tissues and fluids. 50% is excreted unchanged in urine.
  • 6.
     Ethambutol isdistributed to most tissues and body fluids, except CSF. Ethambutol does not penetrate intact meninges, but 10 to 50% may penetrate the meninges of patients with tuberculous meningitis.
  • 7.
     Rifampin—High tovery high (89%). Isoniazid—Very low (0 to 10%). Pyrazinamide—Low (10 to 20%). Pyrazinoic acid—Low (approximately 31%). Ethambutol—Low (20 to 30%).
  • 8.
     Up to15% of ethambutol is metabolized to inactive metaboliteIsoniazid—1 to 2 hours{08}{09}.   Pyrazinamide—1 to 2 hours Pyrazinoic acid—4 to 5 hours Ethambutol—2 to 4 hours Time to peak serum concentration Rifampin—1.5 to 4 hours after oral administration
  • 9.
     Ethambutol: 2 to5 mcg/mL after a single dose of 25 mg/kg.
  • 10.
     Ethambutol— Renal; byglomerular filtration and tubular secretion; up to 80% excreted within 24 hours (at least 50% excreted unchanged and up to 15% as inactive metabolites).  Fecal; 20% excreted unchanged.  In dialysis— ethambutol is removed from the blood by hemodialysis and peritoneal dialysis.
  • 11.
     Incidence morefrequent: Hepatitis (dark urine; yellow eyes or skin) hepatitis prodromal symptoms (loss of appetite; nausea and vomiting; unusual tiredness or weakness) peripheral neuritis (clumsiness or unsteadiness; numbness, tingling, burning, or pain in hands and feet )
  • 12.
    “Flu-like” syndrome (chills;difficulty in breathing; dizziness; fever; headache; muscle and bone pain; shivering) gouty arthritis, acute (chills; pain and swelling of joints, especially big toe, ankle, or knee; tense, hot skin over affected joints) hypersensitivity (itching; redness; skin rash). Incidence less frequent
  • 13.
     Blood dyscrasias(sore throat; unusual bleeding or bruising) interstitial nephritis (bloody or cloudy urine; greatly decreased frequency of urination or amount of urine) neurotoxicity (seizures; mental depression; mood or other mental changes ) retrobulbar optic neuritis (blurred vision or loss of vision, with or without eye pain). Incidence rare
  • 14.
     Before takingethambutol, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems.  Before using this medication, tell your doctor or pharmacist your medical history, especially of: eye problems (such as optic neuritis, cataracts, diabetic retinopathy),liver disease, kidney disease, alcohol use.
  • 15.
    Ethambutol crosses theplacenta, resulting in fetal plasma concentrations that are approximately 30% of maternal plasma concentrations. However, problems in humans have not been documented.
  • 16.
     Disulfiram (concurrentuse in alcoholics may result in increased incidence of CNS effects such as dizziness, incoordination, irritability, or insomnia; reduced dosage or discontinuation of disulfiram may be necessary.
  • 17.
     For specificinformation on the agents used in the management of rifampin, isoniazid, pyrazinamide, and ethambutol overdose, : • Pyridoxine (Systemic) in monograph; • Diazepam in Benzodiazepines (Systemic)monograph; and/or • Thiopental in Barbiturates (Systemic) monograph.
  • 18.
     Conditions affectinguse, especially: Hypersensitivity to rifampin, isoniazid, pyrazinamide, ethionamide, niacin (nicotinic acid), rifabutin, rifapentine, or other chemically related medications  Pregnancy—Rifampin, isoniazid, and ethambutol cross the placenta  Breast-feeding—Rifampin, isoniazid, pyrazinamide, and ethambutol are distributed into breast milk  Use in children——Ethambutol generally is not recommended in children whose visual acuity cannot be monitored (younger than 6 years of age)
  • 19.
     » Regularvisits to physician to check progress, as well as ophthalmologic examinations if signs of optic neuritis occur  » Checking with physician if no improvement within 2 to 3 weeks  » Using an alternate method of contraception if taking estrogen-containing oral contraceptives concurrently  » Avoiding alcoholic beverages while taking this medication  » Checking with physician if vascular reactions occur following concurrent ingestion of cheese or fish with isoniazid-containing medication  » Checking with physician if blurred vision or loss of vision occurs  » Medication causes urine, feces, saliva, sputum, sweat, and tears to turn reddish-orange to reddish-brown and may also permanently discolor soft contact lenses; avoiding the wearing of soft contact lenses
  • 20.